Federal support ending for Resource Utilization Groups III and IV on federally required assessments for patients effective Oct. 1, 2023.
Medicaid Bulletin
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.
Effective with date of service Jan. 27, 2023, Medicaid and NC Health Choice cover lenacapavir injection
Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)
Pegfilgrastim-FpgkInjection, for Subcutaneous Use (Stimufend®) HCPCS Code J3590 - Billing Guidelines
Effective with date of service Jan. 23, 2023, the Medicaid and NC Health Choice programs cover pegfilgrastim-fpgk
Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).
Effective with date of service Jan. 30, 2023, the Medicaid and NC Health Choice programs cover bendamustine hydrochloride injection, for intravenous use (Baxter).
In compliance with federal requirements, beneficiary consent is required for all voluntary sterilizations.
Effective immediately, all providers must use the Electronic Visit Verification vendor of their choice for every home health visit.
Effective April 1, 2023, NC Medicaid covers ambulatory blood pressure monitoring. This helps confirm or exclude suspected hypertension.
Clarifies requirements related to Research Based-Behavioral Health Treatment and Specialized Consultative Services and New Taxonomy